Tri-Sprintec (ethinyl estradiol / norgestimate) Drug Interactions
16 major drug interactions
314 moderate drug interactions
146 minor drug interactions
Common medications checked in combination with Tri-Sprintec (ethinyl estradiol / norgestimate)
Adderall (amphetamine / dextroamphetamine)- Adderall XR (amphetamine / dextroamphetamine)
- Cymbalta (duloxetine)
- Effexor XR (venlafaxine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- fluoxetine
- gabapentin
- ibuprofen
- levothyroxine
- Lexapro (escitalopram)
- lorazepam
- metformin
- omeprazole
- Singulair (montelukast)
- Topamax (topiramate)
- trazodone
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zoloft (sertraline)
Check for interactions with Tri-Sprintec (ethinyl estradiol / norgestimate)
Type in a drug name and select a drug from the list.
You should also know about...
Tri-Sprintec (ethinyl estradiol / norgestimate) alcohol/food Interactions
There are 6 alcohol/food interactions with Tri-Sprintec (ethinyl estradiol / norgestimate)
Tri-Sprintec (ethinyl estradiol / norgestimate) disease Interactions
There are 18 disease interactions with Tri-Sprintec (ethinyl estradiol / norgestimate) which include:
- Abnormal Vaginal Bleeding
- Carcinomas (Estrogenic)
- Hypercalcemia In Breast Cancer
- Hypertension
- Thromboembolism/Cardiovascular
- Hepatic Neoplasms
- Liver Disease
- Thromboembolism
- Gallbladder Disease
- Hypercalcemia
- Hyperlipidemia
- Liver Disease
- Depression
- Fluid Retention
- Glucose Intolerance
- Thyroid Function Tests
- Hyperlipidemia
- Weight Gain
See also...
- Side Effects of Tri-Sprintec (ethinyl estradiol / norgestimate)
- Tri-Sprintec (ethinyl estradiol / norgestimate) Consumer Information
Drug Interaction Classification
The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2013 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
